Fortem Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.19M | Sell |
6,406
-1,449
| -18% | -$269K | 0.38% | 68 |
|
2025
Q1 | $1.65M | Sell |
7,855
-780
| -9% | -$163K | 0.64% | 45 |
|
2024
Q4 | $1.53M | Buy |
8,635
+126
| +1% | +$22.4K | 0.59% | 43 |
|
2024
Q3 | $1.68M | Buy |
8,509
+1,362
| +19% | +$269K | 0.68% | 38 |
|
2024
Q2 | $1.23M | Buy |
7,147
+194
| +3% | +$33.3K | 0.53% | 61 |
|
2024
Q1 | $1.27M | Buy |
6,953
+1,078
| +18% | +$196K | 0.56% | 62 |
|
2023
Q4 | $910K | Sell |
5,875
-1,200
| -17% | -$186K | 0.45% | 75 |
|
2023
Q3 | $1.05M | Sell |
7,075
-1,748
| -20% | -$261K | 0.62% | 46 |
|
2023
Q2 | $1.19M | Sell |
8,823
-2,516
| -22% | -$339K | 0.7% | 44 |
|
2023
Q1 | $1.81M | Sell |
11,339
-1,110
| -9% | -$177K | 1.18% | 24 |
|
2022
Q4 | $2.01M | Sell |
12,449
-48
| -0.4% | -$7.76K | 1.18% | 24 |
|
2022
Q3 | $1.68M | Buy |
12,497
+655
| +6% | +$87.9K | 1.16% | 20 |
|
2022
Q2 | $1.81M | Buy |
11,842
+9,994
| +541% | +$1.53M | 1.19% | 17 |
|
2022
Q1 | $300K | Sell |
1,848
-1,359
| -42% | -$221K | 0.13% | 138 |
|
2021
Q4 | $434K | Sell |
3,207
-25
| -0.8% | -$3.38K | 0.2% | 121 |
|
2021
Q3 | $349K | Buy |
3,232
+25
| +0.8% | +$2.7K | 0.18% | 132 |
|
2021
Q2 | $361K | Sell |
3,207
-14,363
| -82% | -$1.62M | 0.18% | 135 |
|
2021
Q1 | $1.9M | Sell |
17,570
-295
| -2% | -$31.9K | 1.1% | 22 |
|
2020
Q4 | $1.91M | Buy |
17,865
+909
| +5% | +$97.4K | 1.15% | 19 |
|
2020
Q3 | $1.49M | Buy |
+16,956
| New | +$1.49M | 1.07% | 28 |
|